HOWL - Biotech Soars On New Price Target And Analyst Rating

2023-08-24 13:04:58 ET

A Massachusetts-based biotech company is turning heads on Thursday after it was announced that Webush Securities initiated coverage on the stock with an outperform rating and a $9.00 price target. Seeing that the stock closed at just $2.58 yesterday, naturally traders got excited!

Shares of %WerewolfTherapeutics (Nasdaq: ) rallied strongly on the new announcement, with shares of this small cap reaching gup to $3.134/share (+21.47%) at the session high. This move could be an indication of things to come given the magnitude of momentum the stock saw!

Werewolf Therapeutics Inc is an innovative %Biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.